Complete Filing Data
Kestrel Group Ltd reported Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents of $16.95 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Kestrel Group Ltd did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 |
|---|---|---|
| Revenues | $34.0M | $3.8M |
| Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax | $695.0K | $0.00 |
| Other Comprehensive Income Loss Tax Portion Attributable To Parent1 | $0.00 | $0.00 |
| Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent | $916.0K | $0.00 |
| Other Comprehensive Income Loss Before Tax Portion Attributable To Parent | $916.0K | $0.00 |
| Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Before Tax Portion Attributable To Parent | $237.0K | $0.00 |
| Net Income Loss | $46.7M | -$1.3M |
| Income Tax Expense Benefit | $68.0K | $30.0K |
| Income Loss From Discontinued Operations Net Of Tax Per Diluted Share | -$0.49 | $0.00 |
| Income Loss From Discontinued Operations Net Of Tax Per Basic Share | -$0.49 | $0.00 |
| Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity | -$2.8M | $0.00 |
| Income Loss From Continuing Operations Per Diluted Share | $8.57 | -$0.47 |
| Income Loss From Continuing Operations Per Basic Share | $8.57 | -$0.47 |
| Income Loss From Continuing Operations | $49.5M | -$1.3M |
| General And Administrative Expense | $29.1M | $5.1M |
| Comprehensive Income Net Of Tax | $47.6M | -$1.3M |
| Income Loss From Equity Method Investments | $24.0K | $0.00 |
| Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments | $49.6M | -$1.3M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenues | $17.4M | $5.6M | $752.0K | $631.0K |
| Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax | $239.0K | $478.0K | $0.00 | $0.00 |
| Other Comprehensive Income Loss Tax Portion Attributable To Parent1 | $0.00 | $0.00 | $0.00 | $0.00 |
| Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent | -$1.5M | $559.0K | $0.00 | $0.00 |
| Other Comprehensive Income Loss Before Tax Portion Attributable To Parent | -$1.5M | $559.0K | $0.00 | $0.00 |
| Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Before Tax Portion Attributable To Parent | -$1.7M | $74.0K | $0.00 | $0.00 |
| Net Income Loss | -$5.1M | $69.9M | -$429.0K | -$547.0K |
| Income Tax Expense Benefit | $7.0K | $3.0K | $0.00 | $0.00 |
| Income Loss From Discontinued Operations Net Of Tax Per Diluted Share | -$0.12 | -$0.11 | $0.00 | $0.00 |
| Income Loss From Discontinued Operations Net Of Tax Per Basic Share | -$0.12 | -$0.11 | $0.00 | $0.00 |
| Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity | -$965.0K | -$495.0K | $0.00 | $0.00 |
| Income Loss From Continuing Operations Per Diluted Share | -$0.53 | $15.16 | -$0.16 | -$0.20 |
| Income Loss From Continuing Operations Per Basic Share | -$0.53 | $15.16 | -$0.16 | -$0.20 |
| Income Loss From Continuing Operations | -$4.1M | $70.4M | -$429.0K | -$547.0K |
| General And Administrative Expense | $10.8M | $5.1M | $1.2M | $1.2M |
| Comprehensive Income Net Of Tax | -$6.5M | $70.5M | -$429.0K | -$547.0K |
| Income Loss From Equity Method Investments | -$24.0K | $0.00 | ||
| Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments | -$4.1M | -$429.0K |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $16.9M | $4.3M | $5.6M |
| OCI Debt Securities Held For Sale Unrealized Holding Gain Loss Before Adjustment And Tax | -$16.0K | $0.00 | |
| Gain Loss On Investments | $7.0M | $0.00 | |
| Deferred Policy Acquisition Cost Amortization Expense | $3.1M | $0.00 | |
| Stockholders Equity | $128.3M | $4.6M | |
| Restricted Cash And Cash Equivalents | $9.1M | $0.00 | |
| Cash And Cash Equivalents At Carrying Value | $7.8M | $4.3M | |
| Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Earn Out Liability | |||
| Treasury Stock Common Value | $51.5M | $0.00 | |
| Retained Earnings Accumulated Deficit | $1.2M | -$5.5M | |
| Premiums Receivable At Carrying Value | $724.0K | $0.00 | |
| Other Investments | $173.4M | $0.00 | |
| Other Assets | $17.6M | $1.2M | |
| Long Term Debt | $174.4M | $0.00 | |
| Loans And Leases Receivable Related Parties | $86.9M | $0.00 | |
| Liability For Claims And Claims Adjustment Expense | $637.2M | $0.00 | |
| Liabilities Of Disposal Group Including Discontinued Operation | $1.1M | $0.00 | |
| Liabilities And Stockholders Equity | $1.01B | $5.5M | |
| Liabilities | $881.7M | $904.0K | |
| Investments | $381.8M | $0.00 | |
| Intangible Assets Net Including Goodwill | $9.3M | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $40.5M | $33.7M | $4.5M | $5.0M |
| OCI Debt Securities Held For Sale Unrealized Holding Gain Loss Before Adjustment And Tax | -$20.0K | $7.0K | $0.00 | $0.00 |
| Gain Loss On Investments | $5.5M | $1.1M | $0.00 | $0.00 |
| Deferred Policy Acquisition Cost Amortization Expense | $1.7M | $394.0K | $0.00 | $0.00 |
| Stockholders Equity | $143.8M | $150.1M | $4.5M | $4.9M |
| Restricted Cash And Cash Equivalents | $27.6M | $14.7M | $0.00 | $0.00 |
| Cash And Cash Equivalents At Carrying Value | $12.9M | $19.0M | $4.5M | $5.0M |
| Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Earn Out Liability | $2.7M | -$2.7M | $0.00 | $0.00 |
| Treasury Stock Common Value | $51.5M | $51.5M | ||
| Retained Earnings Accumulated Deficit | $19.0M | $24.0M | ||
| Premiums Receivable At Carrying Value | $9.7M | $10.4M | ||
| Other Investments | $171.8M | $162.1M | ||
| Other Assets | $24.9M | $26.8M | ||
| Long Term Debt | $174.1M | $173.8M | ||
| Loans And Leases Receivable Related Parties | $101.7M | $107.5M | ||
| Liability For Claims And Claims Adjustment Expense | $677.7M | $723.4M | ||
| Liabilities Of Disposal Group Including Discontinued Operation | $734.0K | $566.0K | ||
| Liabilities And Stockholders Equity | $1.13B | $1.16B | ||
| Liabilities | $986.7M | $1.01B | ||
| Investments | $414.3M | $412.3M | ||
| Intangible Assets Net Including Goodwill | $10.4M | $11.4M |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 |
|---|---|---|
| Operating Cash Flow * | -$96.1M | -$1.3M |
| Increase Decrease In Unearned Premiums Net | $6.5M | $0.00 |
| Proceeds From Sale Of Available For Sale Securities Debt | $62.8M | $0.00 |
| Proceeds From Sale And Maturity Of Other Investments | $3.0M | $0.00 |
| Proceeds From Maturities Prepayments And Calls Of Debt Securities Investing Activities | $85.2M | $0.00 |
| Payments To Acquire Other Investments | $9.5M | $0.00 |
| Payments To Acquire Marketable Securities | $95.6M | $0.00 |
| Payments To Acquire Equity Method Investments | $1.1M | $0.00 |
| Payments Of Dividends Common Stock | $40.0M | $0.00 |
| Payments For Proceeds From Other Investing Activities | $21.0K | $0.00 |
| Net Cash Provided By Used In Investing Activities | $146.9M | $0.00 |
| Net Cash Provided By Used In Financing Activities | -$40.0M | $0.00 |
| Increase Decrease In Unearned Premiums | -$6.5M | $0.00 |
| Increase Decrease In Reinsurance Recoverable | -$2.6M | $0.00 |
| Increase Decrease In Premiums Receivable | -$9.9M | $0.00 |
| Increase Decrease In Other Operating Assets | $1.5M | -$1.5M |
| Increase Decrease In Liability For Claims And Claims Adjustment Expense Reserve | -$54.3M | $0.00 |
| Increase Decrease In Funds Held Under Reinsurance Agreements | $158.0K | $0.00 |
| Increase Decrease In Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Held For Sale | -$1.5M | $0.00 |
| Increase Decrease In Accrued Liabilities And Other Operating Liabilities | -$18.7M | -$1.6M |
| Increase Decrease In Accrued Investment Income Receivable | $836.0K | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Operating Cash Flow * | ||||
| Increase Decrease In Unearned Premiums Net | $2.9M | $1.3M | $0.00 | $0.00 |
| Proceeds From Sale Of Available For Sale Securities Debt | $7.9M | $7.3M | ||
| Proceeds From Sale And Maturity Of Other Investments | ||||
| Proceeds From Maturities Prepayments And Calls Of Debt Securities Investing Activities | ||||
| Payments To Acquire Other Investments | ||||
| Payments To Acquire Marketable Securities | ||||
| Payments To Acquire Equity Method Investments | ||||
| Payments Of Dividends Common Stock | ||||
| Payments For Proceeds From Other Investing Activities | ||||
| Net Cash Provided By Used In Investing Activities | ||||
| Net Cash Provided By Used In Financing Activities | ||||
| Increase Decrease In Unearned Premiums | ||||
| Increase Decrease In Reinsurance Recoverable | ||||
| Increase Decrease In Premiums Receivable | ||||
| Increase Decrease In Other Operating Assets | ||||
| Increase Decrease In Liability For Claims And Claims Adjustment Expense Reserve | ||||
| Increase Decrease In Funds Held Under Reinsurance Agreements | ||||
| Increase Decrease In Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Held For Sale | -$1.8M | -$1.1M | $0.00 | $0.00 |
| Increase Decrease In Accrued Liabilities And Other Operating Liabilities | ||||
| Increase Decrease In Accrued Investment Income Receivable |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Weighted Average Number Of Shares Outstanding Basic | 5.7M | 2.7M | |
| Weighted Average Number Of Diluted Shares Outstanding | 5.7M | 2.7M | |
| Earnings Per Share Diluted | $8.08 | $-0.47 | |
| Earnings Per Share Basic | $8.08 | $-0.47 | |
| Common Stock Par Or Stated Value Per Share | $0.01 | $0.01 | |
| Common Stock Shares Outstanding | 7.7M | 2.7M | 2.7M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Weighted Average Number Of Shares Outstanding Basic | 7.7M | 4.6M | 2.7M | 2.7M |
| Weighted Average Number Of Diluted Shares Outstanding | 7.7M | 4.6M | 2.7M | 2.7M |
| Earnings Per Share Diluted | $-0.65 | $15.05 | $-0.16 | $-0.20 |
| Earnings Per Share Basic | $-0.65 | $15.05 | $-0.16 | $-0.20 |
| Common Stock Par Or Stated Value Per Share | $0.01 | $0.01 | ||
| Common Stock Shares Outstanding | 7.7M | 7.7M |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 |
|---|---|---|
| Premiums Written Net | $6.2M | $0.00 |
| Premiums Written Gross | $6.1M | $0.00 |
| Premiums Earned Net | $12.7M | $0.00 |
| Policyholder Benefits And Claims Incurred Net | $9.0M | $0.00 |
| Investment Income Net | $8.3M | $213.0K |
| Interest And Amortization Expenses Net | $9.9M | $0.00 |
| Foreign Currency Transactionand Other Gain Lossbefore Tax | -$1.7M | $0.00 |
| Fee Income | $6.1M | $3.6M |
| Business Combination Bargain Purchase Gain Recognized Amount | $68.3M | $0.00 |
| Benefits Losses And Expenses Net | -$15.5M | $5.1M |
| Unearned Premiums | $17.4M | $0.00 |
| Reinsurance Recoverable For Unpaid Claims And Claims Adjustments | $461.2M | $0.00 |
| Funds Held Under Reinsurance Agreements Asset | $11.0M | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Premiums Written Net | $3.9M | $1.1M | $0.00 | $0.00 |
| Premiums Written Gross | $3.8M | $1.1M | $0.00 | $0.00 |
| Premiums Earned Net | $6.8M | $2.4M | $0.00 | $0.00 |
| Policyholder Benefits And Claims Incurred Net | $10.4M | -$6.0M | $0.00 | $0.00 |
| Investment Income Net | $3.5M | $1.5M | $52.0K | $54.0K |
| Interest And Amortization Expenses Net | $4.1M | $1.5M | $0.00 | $0.00 |
| Foreign Currency Transactionand Other Gain Lossbefore Tax | $2.9M | -$5.0M | $0.00 | $0.00 |
| Fee Income | $1.6M | $544.0K | $700.0K | $577.0K |
| Business Combination Bargain Purchase Gain Recognized Amount | $0.00 | $73.6M | $0.00 | $0.00 |
| Benefits Losses And Expenses Net | $21.5M | -$64.9M | $1.2M | $1.2M |
| Unearned Premiums | $19.6M | $22.6M | ||
| Reinsurance Recoverable For Unpaid Claims And Claims Adjustments | $492.8M | $520.5M | ||
| Funds Held Under Reinsurance Agreements Asset | $11.9M | $12.1M |
Most recent annual filing with the SEC: March 13, 2026
Data sourced from SEC EDGAR public filings as of August 4, 2026.